Tony Bruno has been a member of the company’s board of directors since November 2018. Mr. Bruno is a highly accomplished senior pharmaceutical executive with broad expertise in legal, business development, and corporate development functions within the industry, as well as significant experience in product licensing and M&A transactions. He has spent over 30 years in the pharmaceutical industry, most recently serving as a strategic advisor to Foamix from 2014 until 2018. He was employed at Warner Chilcott from 2000 to 2011, most recently as Executive Vice President with responsibility for all business development activities including product acquisitions and divestitures as well as licensing agreements. Prior to this, he served as General Counsel for Warner Chilcott, where he was responsible for all legal activities. From 1984 to 2000, Mr. Bruno held several positions of increasing responsibility within Warner Lambert’s legal division, culminating as General Counsel to the company’s pharmaceutical business. Prior to working in the pharmaceutical industry, Mr. Bruno began his legal career as an associate with Shearman & Sterling in New York in 1981. He received a JD with honors from George Washington Law School, and graduated magna cum laude from Syracuse University with a BA in political science.